Credit rating
AA+Stable
AA+Stable
At issuance: AA+ · ICRA
Latest agency surveillance grade, refreshed daily. A rating can migrate after issuance, so it may differ from the grade the bond was issued with.
Recent trading
An actual exchange-cleared trade in the last 30 days; independent of any platform quote.
Where to buy this bond Best offer is the highest yield (lowest effective price) for this exact ISIN among the SEBI-registered online bond platforms (OBPPs) we track. We only show quotes refreshed in the last 24 hours, so a platform that has not been re-checked recently will not appear here. Capera does not sell bonds and does not earn from which platform wins; always confirm on the platform before you buy.
The same security, priced across the online bond platforms we track. Capera does not sell bonds; we show every platform's quote so you can pick the best yield.
No live platform quotes for this ISIN yet.
Ask us to watch it and we'll tell you the moment a platform lists this ISIN, with the live yield, so you never have to keep checking.
1 mo, 5 d to maturity
ISIN
INE634S07025Type
NCD
Coupon
7.99%
PayoutTwice a year
Half-yearly
Face value
₹1,00,000
Issue sizeTotal amount raised in this issue (face value × units issued).
₹1,250 Cr
Listed
Listed
TaxInterest is taxed at your income-tax slab rate; no special exemption.
Taxable
Other bonds by MANKIND PHARMA LIMITED
Full issuer page →Same issuer, different tenors. Each line is a distinct security; click any to compare it across platforms against the live exchange-traded yield.
Where this bond sits on the curve
The amber point is this security; each navy point is another of the issuer's traded lines. Every line carries its own seniority, security cover, options and covenants, so the shape is context, not an apples-to-apples curve.
| The latest agency surveillance grade where one is on record; otherwise the grade at issue. A rating can migrate after issuance, so the two can differ. | ||||
|---|---|---|---|---|
Mankind PharmaINE634S07033NCD | AA+ | 7.97% | 16 Nov 20271.2y left | 7.66% |
Secured: backed by a charge over the issuer's assets. Unmarked lines are unsecured.
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Questions
What is INE634S07025 rated?
This security (INE634S07025) currently carries a AA+ (CRISIL), AA+ (ICRA) grade under live agency surveillance. At issuance it was rated AA+. Ratings are per-security, so other instruments from MANKIND PHARMA LIMITED can carry different grades, and surveillance grades can migrate from the issue-time grade.
Where can I buy INE634S07025?
We do not yet have live platform quotes for this ISIN. Capera does not sell bonds; when a SEBI-registered online bond platform lists it, its price appears here.
Has INE634S07025 traded recently?
Yes, it last traded 11 days ago at a yield of 6.97%.
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.
Neutral by design
We don't sell bonds. We show you everyone's price.
Capera compares the same security across every online bond platform and against the live exchange-traded yield, so you always know where the best deal is.
Explore Capera →